Analysts Are Recommending Ensysce Biosciences Inc (ENSC) As A Buy Candidate

Ensysce Biosciences Inc (NASDAQ:ENSC) has a beta value of 1.20 and has seen 80.84 million shares traded in the recent trading session. The company, currently valued at $6.00M, closed the recent trade at $3.64 per share which meant it gained $1.77 on the day or 94.65% during that session. The ENSC stock price is -303.02% off its 52-week high price of $14.67 and 55.49% above the 52-week low of $1.62. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.31 million shares traded. The 3-month trading volume is 75.73K shares.

The consensus among analysts is that Ensysce Biosciences Inc (ENSC) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.

Ensysce Biosciences Inc (NASDAQ:ENSC) trade information

Sporting 94.65% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ENSC stock price touched $3.64 or saw a rise of 21.38%. Year-to-date, Ensysce Biosciences Inc shares have moved -55.28%, while the 5-day performance has seen it change 62.50%. Over the past 30 days, the shares of Ensysce Biosciences Inc (NASDAQ:ENSC) have changed 1.11%. Short interest in the company has seen 31447.0 shares shorted with days to cover at 1.62.

Ensysce Biosciences Inc (ENSC) estimates and forecasts

The company’s shares have gained 36.48% over the past 6 months.

ENSC Dividends

Ensysce Biosciences Inc is expected to release its next earnings report on 2025-Mar-09 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Ensysce Biosciences Inc (NASDAQ:ENSC)’s Major holders

Insiders own 0.63% of the company shares, while shares held by institutions stand at 8.56% with a share float percentage of 8.62%. Investors are also buoyed by the number of investors in a company, with Ensysce Biosciences Inc having a total of 8.0 institutions that hold shares in the company. The top two institutional holders are PLANTE MORAN FINANCIAL ADVISORS, LLC with over 20.0 shares worth more than $10.0. As of 2024-06-30, PLANTE MORAN FINANCIAL ADVISORS, LLC held 0.0004% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of Feb 28, 2025 , the former fund manager holds about 0.37% shares in the company for having 6.08 shares of worth $21444.0 while later fund manager owns 1.34 shares of worth $4719.0 as of Feb 28, 2025 , which makes it owner of about 0.08% of company’s outstanding stock.